Skip to content Skip to footer

Galderma to Acquire ZO Skin Health for $1.5B

Shots: Galderma signed an agreement to acquire 100% of ZO Skin Health for an enterprise value of $1.5B in an all-cash transaction, expanding its dermatological skincare portfolio alongside Cetaphil and Alastin ZO Skin Health offers more than 40 skincare products and serves over 16,500 physician, medical spa, and online accounts across more than 40 countries.…

Read more